Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Jamieson Wellness Inc

Consumer Defensive CA JWEL

34.53CAD
-0.31(0.89%)

Last update at 2026-06-03T20:00:00Z

Day Range

34.5335.39
LowHigh

52 Week Range

30.0139.05
LowHigh

Fundamentals

  • Previous Close 34.84
  • Market Cap1416.01M
  • Volume53948
  • P/E Ratio23.71
  • Dividend Yield-%
  • EBITDA128.58M
  • Revenue TTM822.06M
  • Revenue Per Share TTM19.65
  • Gross Profit TTM 338.33M
  • Diluted EPS TTM1.44

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 89.84M 75.80M 65.67M 70.50M 70.47M
Minority interest -2.02700M 0.78M 1.84M - -
Net income 62.44M 51.91M 47.88M 52.81M 52.08M
Selling general administrative 224.57M 181.76M 146.17M 115.15M 86.41M
Selling and marketing expenses - - - - -
Gross profit 338.33M 275.61M 233.56M 198.34M 162.44M
Reconciled depreciation 19.66M 18.53M 20.32M 17.25M 14.27M
Ebit 113.76M 96.07M 87.39M 83.19M 76.03M
Ebitda 133.42M 114.60M 102.88M 100.44M 90.30M
Depreciation and amortization 19.66M 18.53M 20.32M 17.25M 14.27M
Non operating income net other - - - - -
Operating income 113.76M 106.28M 87.39M 83.19M 76.03M
Other operating expenses 708.30M 627.50M 588.78M 464.18M 375.00M
Interest expense 25.84M 20.27M 22.78M 12.42M 5.66M
Tax provision 25.37M 24.66M 19.63M 17.70M 18.38M
Interest income - 30.48M 29.58M 12.69M 5.57M
Net interest income -22.40900M -20.27200M -22.78400M -12.41700M -5.65700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 25.37M 24.66M 19.63M 17.70M 18.38M
Total revenue 822.06M 733.78M 676.17M 547.37M 451.03M
Total operating expenses 224.57M 169.33M 588.78M 115.15M 86.41M
Cost of revenue 483.72M 458.17M 442.61M 349.03M 288.59M
Total other income expense net -23.92300M -30.48000M 1.07M -12.68600M -5.56500M
Discontinued operations - - - - -
Net income from continuing ops 64.46M 51.13M 46.04M 52.81M 52.08M
Net income applicable to common shares - 51.91M 47.88M 52.81M 52.08M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1215.03M 1208.79M 1143.57M 1107.26M 652.48M
Intangible assets 362.75M 377.21M 366.52M 367.20M 192.68M
Earning assets - - - - -
Other current assets 7.79M 6.80M 9.04M 10.88M 7.18M
Total liab 685.52M 660.41M 662.38M 675.67M 310.45M
Total stockholder equity 485.42M 505.18M 438.93M 431.59M 342.02M
Deferred long term liab - - - - -
Other current liab 76.49M 30.66M 7.55M 26.04M 25.70M
Common stock 333.35M - 312.59M 307.20M 268.21M
Capital stock 333.35M 326.22M 312.59M 307.20M 268.21M
Retained earnings 90.37M 99.11M 80.65M 85.48M 59.00M
Other liab - - - 95.63M 56.84M
Good will 279.64M 287.50M 274.41M 272.92M 122.97M
Other assets - - - 3.03M 2.70M
Cash 41.23M 44.79M 36.86M 26.24M 6.78M
Cash and equivalents - - - - -
Total current liabilities 174.15M 172.68M 145.33M 154.81M 83.62M
Current deferred revenue - - 53.78M - -
Net debt 430.80M 263.50M 426.12M 373.76M 142.35M
Short term debt 4.14M - 7.55M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total 472.02M - 462.99M 400.00M 149.12M
Other stockholder equity 27.49M - 33.79M 17.11M 14.79M
Property plant equipment - - - 111.71M 96.98M
Total current assets 451.34M 436.94M 392.86M 352.40M 237.15M
Long term investments - - - - -
Net tangible assets - - - -208.53000M 26.37M
Short term investments - - 3.29M - -
Net receivables 199.25M 227.26M 164.50M 160.80M 104.19M
Long term debt 414.60M 308.29M 325.00M 400.00M 149.12M
Inventory 203.08M 154.66M 182.46M 154.49M 119.01M
Accounts payable 93.51M 124.84M 76.46M 128.77M 57.92M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 34.20M - 11.89M 21.79M 0.02M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 2.88M - -
Deferred long term asset charges - - - - -
Non current assets total 763.69M 771.85M 750.71M 754.86M 415.33M
Capital lease obligations - - - - -
Long term debt total - - - 461.93M 170.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -10.16400M -35.13100M -256.53000M -22.28400M
Change to liabilities - - - 0.00000M 0.00000M
Total cashflows from investing activities -22.24600M -10.16400M -35.13100M -256.53000M -22.28400M
Net borrowings 100.70M -22.27300M -79.53600M 247.54M -3.14000M
Total cash from financing activities -62.78300M -45.43400M 14.04M 225.41M -16.51200M
Change to operating activities - - - -27.01200M -27.32600M
Net income 62.44M 51.13M 46.04M 52.81M 52.08M
Change in cash -3.56200M 7.92M 10.62M 19.46M 5.61M
Begin period cash flow 44.79M 36.86M 26.24M 6.78M 1.17M
End period cash flow 41.23M 44.79M 36.86M 26.24M 6.78M
Total cash from operating activities 82.51M 61.58M 31.71M 50.59M 44.41M
Issuance of capital stock - 0.00000M 84.58M - -
Depreciation 19.66M 18.53M 20.32M 17.25M 14.27M
Other cashflows from investing activities -8.69200M -0.98300M -0.47300M -242.59700M -0.78600M
Dividends paid 37.18M -33.45900M -30.25700M 26.32M 22.11M
Change to inventory -48.42500M 27.80M -14.27100M - -
Change to account receivables 21.44M -63.53200M -3.70100M - -
Sale purchase of stock -139.43500M -0.94900M -29.00400M 4.19M 8.73M
Other cashflows from financing activities -5.60900M 11.25M 152.84M 343.58M 81.62M
Change to netincome - - - 7.54M 5.38M
Capital expenditures 12.71M 10.16M 9.31M 14.57M 22.28M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -17.89900M -31.16900M -32.12600M -27.01200M -27.32600M
Stock based compensation 8.22M 7.12M 5.65M 4.76M 5.48M
Other non cash items 13.95M 11.67M -9.93800M 1.12M 0.38M
Free cash flow 69.80M 51.41M 22.41M 36.02M 22.12M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JWEL
Jamieson Wellness Inc		 -0.31 0.89% 34.53 23.71 16.29 1.72 2.95 2.20 13.69
SAP
Saputo Inc		 0.55 1.30% 42.91 24.58 16.86 0.82 2.33 0.98 11.53
PBH
Premium Brands Holdings Corporation		 -0.24 0.26% 91.44 94.79 13.44 0.59 2.66 1.04 15.32
MFI
Maple Leaf Foods Inc.		 0.52 1.75% 30.26 87.71 18.83 0.95 2.82 1.23 11.26
HLF
High Liner Foods Incorporated		 0.04 0.28% 14.45 8.28 8.19 0.38 0.70 0.57 6.53

Reports Covered

Stock Research & News

View All

Profile

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Jamieson Wellness Inc

1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9

Key Executives

Name Title Year Born
Mr. Michael Pilato Pres, CEO & Director 1975
Mr. Christopher Snowden CFO & Corp. Sec. NA
Ms. Regan Stewart Chief Operations & People Officer NA
Mr. John Doherty Chief Science & Innovation Officer 1973
Mr. Don Bird Exec. VP of USA & Global Strategic Partners 1964
Ruth Winker Corp. Communications Director NA
Mr. Eric Bentz Sr. VP of Global Marketing & MD of China NA
Mr. Paul Galbraith Sr. VP & MD of Canada NA
Mr. Joel Scales Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce NA
Mr. Michael Pilato President, CEO & Director 1975

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.